UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

( MARK ONE )

x	Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2006.

o	Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from ___________to ________.

Commission File No. 0-16469

INTER PARFUMS, INC.

(Exact name of registrant as specified in its charter)

Delaware	13-3275609
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

551 Fifth Avenue, New York, New York 10176

(Address of Principal Executive Offices) (Zip Code)

(212) 983-2640

(Registrants telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer or a non-accelerated filer. See definition of “accelerated filer” and “large accelerated filer” in Rule 12b-2 of the Exchange Act).

Large accelerated filer o Accelerated filer x Non-accelerated filer o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

At November 6, 2006 there were 20,353,910 shares of common stock, par value $.001 per share, outstanding.

INDEX

Part I. Financial Information		Page Number

Item 1.Financial Statements		1

Consolidated Balance Sheets
as of September 30, 2006 (unaudited)
and December 31, 2005		2

Consolidated Statements of Income
for the Three and Nine Months Ended
September 30, 2006 (unaudited)
and September 30, 2005 (unaudited)		3

Consolidated Statements of Cash Flows
for the Nine Months Ended
September 30, 2006 (unaudited) and
September 30, 2005 (unaudited)		4

Notes to Consolidated Financial Statements		5

Item 2. Management's Discussion and Analysis of
Financial Condition and Results of Operations		12

Item 3. Quantitative and Qualitative Disclosures
About Market Risk		22

Item 4. Controls and Procedures		23

Part II. Other Information		23

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		23

Item 6. Exhibits		24

Signatures		24

Certifications		25

INTER PARFUMS, INC. AND SUBSIDIARIES

Part I. Financial Information

Item 1. Financial Statements

In our opinion, the accompanying unaudited consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary to present fairly our financial position, results of operations and cash flows for the interim periods presented. We have condensed such financial statements in accordance with the rules and regulations of the Securities and Exchange Commission. Therefore, such financial statements do not include all disclosures required by accounting principles generally accepted in the United States of America. These financial statements should be read in conjunction with our audited financial statements for the year ended December 31, 2005 included in our annual report filed on Form 10-K.

The results of operations for the nine months ended September 30, 2006 are not necessarily indicative of the results to be expected for the entire calendar year.

Page 1

INTER PARFUMS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands except share and per share data)

*ASSETS*
	September 30, 2006			December 31, 2005
	(unaudited)
Current assets:
Cash and cash equivalents	$	40,683		$	42,132
Short-term investments		13,300			17,400
Accounts receivable, net		110,452			82,231
Inventories		70,995			48,631
Receivables, other		2,559			2,119
Other current assets		5,545			4,213
Income tax receivable		449			104
Deferred tax assets		3,677			3,011

Total current assets		247,660			199,841

Equipment and leasehold improvements, net		7,430			5,835

Trademarks, licenses and other intangible assets, net		55,498			30,136

Goodwill		4,791			4,476

Other assets		600			622

	$	315,979		$	240,910

*LIABILITIES AND SHAREHOLDERS’ EQUITY*
Current liabilities:
Loans payable - banks	$	10,250		$	989
Current portion of long-term debt		4,051			3,775
Accounts payable		44,155			40,359
Accrued expenses		60,263			21,555
Income taxes payable		1,184			1,269
Dividends payable		813			810

Total current liabilities		120,716			68,757

Long-term debt, less current portion		7,311			9,437

Deferred tax liability		1,951			1,783

Put option		1,172			743

Minority interest		39,190			32,463

Shareholders’ equity:
Preferred stock, $.001 par; authorized 1,000,000 shares; none issued
Common stock, $.001 par; authorized 100,000,000 shares; outstanding 20,335,910 and 20,252,310 shares at September 30, 2006 and December 31, 2005, respectively		20			20
Additional paid-in capital		37,363			36,640
Retained earnings		123,032			112,802
Accumulated other comprehensive income		10,533			3,574
Treasury stock, at cost, 6,302,768 common shares at September 30, 2006 and December 31, 2005		(25,309	)		(25,309	)

		145,639			127,727

	$	315,979		$	240,910

See notes to consolidated financial statements.

Page 2

INTER PARFUMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(In thousands except per share data)

(Unaudited)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2006			2005			2006			2005

Net sales	$	89,690		$	75,446		$	230,876		$	207,875

Cost of sales		41,002			33,089			102,221			90,346

Gross margin		48,688			42,357			128,655			117,529

Selling, general and administrative		39,263			35,124			103,664			94,286

Income from operations		9,425			7,233			24,991			23,243

Other expenses (income):
Interest expense		311			92			830			692
(Gain) on foreign currency		(66	)		(107	)		(447	)		(104	)
Interest and dividend (income)		(282	)		(268	)		(1,297	)		(962	)
(Gain) on subsidiary’s issuance of stock		(5	)		(26	)		(17	)		(11	)

		(42	)		(309	)		(931	)		(385	)

Income before income taxes and minority interest		9,467			7,542			25,922			23,628

Income taxes		3,192			2,545			8,827			8,520

Income before minority interest		6,275			4,997			17,095			15,108

Minority interest in net income of consolidated subsidiary		1,630			1,243			4,838			3,737

Net income	$	4,645		$	3,754		$	12,257		$	11,371

Net income per share:
Basic	$	0.23		$	0.19		$	0.60		$	0.57
Diluted	$	0.23		$	0.18		$	0.60		$	0.56

Weighted average number of shares outstanding:
Basic		20,322			20,189			20,302			20,023
Diluted		20,546			20,556			20,551			20,485

See notes to consolidated financial statements.

Page 3

INTER PARFUMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Nine months ended September 30,
	2006			2005
Cash flows from operating activities:
Net income	$	12,257		$	11,371
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization		3,750			3,238
Provision for doubtful accounts		45			66
Noncash stock compensation		473			--
Loss (gain) on sale of trademark		243			(150	)
Minority interest in net income of consolidated subsidiary		4,838			3,737
Deferred tax (benefit)		(479	)		(625	)
Change in fair value of put option		369			187
(Gain) on subsidiary’s issuance of stock		(17	)		(11	)
Changes in:
Accounts receivable		(22,667	)		(25,290	)
Inventories		(19,381	)		2,991
Other assets		(1,268	)		(4,711	)
Accounts payable and accrued expenses		15,816			18,135
Income taxes payable, net		(533	)		(1,231	)

Net cash provided by (used in) operating activities		(6,554	)		7,707

Cash flows from investing activities:
Purchases of short-term investments		--			(2,100	)
Proceeds from sale of short-term investments		4,100			2,000
Purchase of equipment and leasehold improvements		(2,793	)		(1,806	)
Payment for licenses, trademarks and other intangible assets		(4,101	)		(343	)
Proceeds from sale of trademark		1,121			185

Net cash (used in) investing activities		(1,673	)		(2,064	)

Cash flows from financing activities:
Increase in loans payable - bank		9,119			5,467
Proceeds from long-term debt		--			--
Repayment of long-term debt		(2,990	)		(3,027	)
Proceeds from sale of stock of subsidiary		681			690
Proceeds from stock-based compensation transactions		657			391
Dividends paid		(2,434	)		(2,196	)
Dividends paid to minority interest		(1,218	)		(1,106	)
Purchases of treasury stock		--			(150	)

Net cash provided by financing activities		3,815			69

Effect of exchange rate changes on cash		2,963			(2,729	)

Net (decrease) increase in cash and cash equivalents		(1,449	)		2,983

Cash and cash equivalents - beginning of period		42,132			23,372

Cash and cash equivalents - end of period	$	40,683		$	26,355

Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest	$	985		$	462
Income taxes		10,228			8,094

See notes to consolidated financial statements.

Page 4

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

1.	Significant Accounting Policies:

The accounting policies we follow are set forth in the notes to our financial statements included in our Form 10-K which was filed with the Securities and Exchange Commission for the year ended December 31, 2005. We also discuss such policies in Part I, Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations, included in this Form 10-Q.

2.	New Accounting Pronouncements:

In March 2006, the Financial Accounting Standards Board (“FASB”) released Statement of Financial Accounting Standards (“SFAS”) 156, Accounting for Servicing of Financial Assets (“SFAS 156”), to simplify accounting for separately recognized servicing assets and servicing liabilities. SFAS 156 amends SFAS 140, Accounting for Transfers and Servicing of Financial Assets and Extinguishments of Liabilities. SFAS 156 permits an entity to choose either the amortization method or the fair value measurement method for measuring each class of separately recognized servicing assets and servicing liabilities after they have been initially measured at fair value. SFAS 156 applies to all separately recognized servicing assets and liabilities acquired or issued after the beginning of an entity’s fiscal year that begins after September 15, 2006. SFAS 156 will be effective as of January 1, 2007. The Company does not believe the adoption of SFAS 156 will have a material impact on the Company’s consolidated financial statements.

In June 2006, the FASB issued FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes - an interpretation of FASB No. 109 (“FIN 48”), which prescribes accounting for and disclosure of uncertainty in tax positions. This interpretation defines the criteria that must be met for the benefits of a tax position to be recognized in the financial statements and the measurement of tax benefits recognized. The provisions of FIN 48 are effective as of the beginning of the Company’s 2007 fiscal year, with the cumulative effect of the change in accounting principle recorded as an adjustment to opening retained earnings. The Company is currently evaluating the impact that the adoption of FIN 48 will have on the Company’s consolidated financial statements.

In September 2006, FASB issued SFAS 157, “Fair Value Measurements” (“SFAS 157”). While the statement does not expand the use of fair value in any new circumstances it defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. This Statement is effective for financial statements issued for fiscal years beginning after November 15, 2007 and interim periods within those fiscal years. The Company is currently evaluating the impact that the adoption of SFAS 157 will have on the Company’s consolidated financial statements.

In September 2006, the SEC issued Staff Accounting Bulletin No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements” (“SAB 108”). SAB 108 provides guidance on how prior year misstatements should be taken into consideration when quantifying misstatements in current year financial statements for purposes of determining whether the current year’s financial statements are materially misstated. SAB 108 permits registrants to record the cumulative effect of initial adoption by recording the necessary “correcting” adjustments to the carrying values of assets and liabilities as of the beginning of that year with the offsetting adjustment recorded to the opening balance of retained earnings only if material under the dual method. SAB 108 is effective for fiscal years ending on or after November 15, 2006. The Company does not believe the adoption of SAB 108 will have a material impact on the Company’s consolidated financial statements.

Page 5

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

2.	New Accounting Pronouncements (continued):

In September 2006, the FASB issued SFAS 158, “Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans, an amendment of FASB Statements No. 87, 88, 106, and 132(R)” (“SFAS 158”). Among other items, SFAS 158 requires recognition of the overfunded or underfunded status of an entity’s defined benefit postretirement plan as an asset or liability in the financial statements, requires the measurement of defined benefit postretirement plan assets and obligations as of the end of the employer’s fiscal year and requires recognition of the funded status of defined benefit postretirement plans in other comprehensive income. SFAS 158 is effective for fiscal years ending after December 15, 2006, and early application is encouraged. The Company is currently evaluating the impact that the adoption of SFAS 158 will have on the Company’s consolidated financial statements.

3.	Share-Based Payments:

Prior to January 1, 2006, we applied the disclosure-only provisions of SFAS 123, "Accounting for Stock-Based Compensation" (“SFAS 123”). In accordance with the provisions of SFAS 123, we applied Accounting Principles Board Opinion No. 25, "Accounting for Stock Issued to Employees" ("APB 25") and related interpretations in accounting for our stock based compensation plans and, accordingly, did not recognize compensation expense for stock options because we issued options at an exercise price equal to the market value at date of grant.

Effective January 1, 2006, we adopted SFAS 123(R), “Share-Based Payment” (“SFAS 123(R)”), which revises SFAS 123 and supersedes APB 25. SFAS 123(R) requires all share-based payments to be recognized in the financial statements based on the fair values using an option-pricing model at the date of grant. We have elected to use the modified prospective method for adoption, which requires compensation expense to be recorded for all unvested stock options beginning in the first quarter of adoption, based on the fair value at the original grant date. Prior year financial statements have not been restated.

Compensation cost for share-based arrangements and the impact of the adoption of SFAS 123(R) during the three and nine months ended September 30, 2006 decreased income before income taxes by $0.24 million and $0.69 million, respectively, decreased net income by $0.12 million and $0.34 million, respectively, reduced basic earnings per share by $0.01 and $0.02, respectively, and decreased diluted earnings per share by $0.01 for the nine months ended September 30, 2006. The adoption of SFAS 123(R) had no impact on cash flow from operating activities or financing activities in the accompanying statements of cash flows.

Page 6

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

3.	Share-Based Payments (continued):

The effect on net income and earnings per share if we had applied the fair value recognition provisions of SFAS 123 to stock-based compensation for the three and nine months ended September 30, 2005 is as follows:

(In thousands except per share data)	Three months ended September 30,			Nine months ended September 30,
	2005			2005

Reported net income	$	3,754		$	11,371
Less: Stock-based employee compensation determined under SFAS 123, net of taxes		(92	)		(921	)

Pro forma net income	$	3,662		$	10,450

Income per share, as reported:
Basic	$	0.19		$	0.57
Diluted	$	0.18		$	0.56

Pro forma net income per share:
Basic	$	0.18		$	0.52
Diluted	$	0.18		$	0.51

The Company maintains a stock option program for key employees, executives, and directors. The plans, all of which have been approved by shareholder vote, provide for the granting of both nonqualified and incentive options. Options granted under the plans vest immediately and are exercisable for a period of five years. It is generally the Company’s policy to issue new shares upon exercise of stock options.

The following table summarizes stock option activity and related information as of September 30, 2006 and does not include information relating to options of Inter Parfums, S.A. granted by Inter Parfums, S.A., our majority owned subsidiary:

	Shares			Weighted Average Exercise Price

Outstanding at January 1, 2006		985,550		$	14.03
Granted		12,000			18.56
Exercised		(83,600	)		7.91
Forfeited or expired		(71,550	)		17.51

Outstanding at September 30, 2006		842,400		$	14.41

Page 7

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

3.	Share-Based Payments (continued):

At September 30, 2006, options for 972,079 shares were available for future grant under the plans.

The weighted average remaining contractual life of options outstanding as of September 30, 2006 is 2.2 years and the aggregate intrinsic value is $4.7 million.

As of September 30, 2006, there was no unrecognized compensation cost related to stock options outstanding on Inter Parfums, Inc. stock as all options were fully vested upon grant. The amount of unrecognized compensation cost related to stock options outstanding of our majority owned subsidiary, Inter Parfums S.A., was 1.7 million euro. Options under these plans vest over a four year period.

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the nine months ended September 30, 2006 and September 30, 2005 were as follows:

	September 30, 2006		September 30, 2005

Cash proceeds from stock options exercised	$	661,119	$	390,701
Tax benefits		0		0
Intrinsic value of stock options exercised		839,401		12,360,511

No tax benefit was recognized from stock options exercised as valuation reserves were allocated to those potential benefits.

The weighted average fair values of the options granted by Inter Parfums, Inc. during the nine months ended September 30, 2006 and 2005 were $6.32 and $4.97 per share, respectively, on the date of grant using the Black-Scholes option pricing model with the following assumptions: dividend yield 0.9% in 2006 and 1.0% in 2005; volatility of 40% in 2006 and 2005; risk-free interest rates at the date of grant, 4.7% in 2006 and 3.5% in 2005; and an expected life of the option of four years in 2006 and 2005.

Stock-based employee compensation determined under the fair value based method, net of related tax effects, includes compensation incurred by Inter Parfums, S.A., our majority owned subsidiary whose stock is publicly traded in France. The weighted average fair values of the options granted by Inter Parfums, S.A. during the nine months ended September 30, 2006 and 2005 were 10.37 euro and 6.08 euro per share, respectively, on the date of grant using the Black-Scholes option pricing model with the following assumptions: dividend yield 0.94% in 2006 and 1.0% in 2005; volatility of 25% in 2006 and 22% in 2005; risk-free interest rates at the date of grant, 4.6% in 2006 and 4.5% in 2005; and an expected life of the option of four years in 2006 and 2005.

Page 8

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

4.	Comprehensive Income:

(In thousands)	Three months ended September 30,						Nine months ended September 30,
	2006			2005			2006		2005
Comprehensive income:
Net income	$	4,645		$	3,754		$	12,257	$	11,371
Other comprehensive income, net of tax:
Foreign currency translation adjustment		(506	)		(182	)		6,931		(10,843	)
Change in fair value of derivatives		26			2			28		(137	)

Comprehensive income	$	4,165		$	3,574		$	19,216	$	391

5.	Segment and Geographic Areas:

The Company manages its business in two segments, European based operations and United States based operations. The European assets are located, and operations are conducted, in France. European operations primarily represent the sales of the prestige brand name fragrances and United States operations primarily represent the sale of mass-market and specialty retail products. Information on the Company’s operations by geographical areas is as follows.

(In thousands)	Three months ended September 30,						Nine months ended September 30,
	2006			2005			2006			2005
Net Sales:
United States	$	13,624		$	8,305		$	31,174		$	26,078
Europe		76,506			67,159			200,788			184,380
Eliminations		(440	)		(18	)		(1,086	)		(2,583	)

	$	89,690		$	75,446		$	230,876		$	207,875

Net Income:
United States	$	212		$	115		$	(1,111	)	$	270
Europe		4,404			3,482			13,349			11,219
Eliminations		29			157			19			(118	)

	$	4,645		$	3,754		$	12,257		$	11,371

6.	Earnings Per Share:

Basic earnings per share are computed using the weighted average number of shares outstanding during each period. Diluted earnings per share are computed using the weighted average number of shares outstanding during each period, plus the incremental shares outstanding assuming the exercise of dilutive stock options and warrants.

Page 9

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

6.	Earnings Per Share (continued):

The following table sets forth the computation of basic and diluted earnings per share:

(In thousands)	Three months ended September 30,				Nine months ended September 30,
	2006		2005		2006		2005
Numerator:
Net income	$	4,645	$	3,754	$	12,257	$	11,371

Denominator:
Weighted average shares		20,322		20,189		20,302		20,023
Effect of dilutive securities:
Stock options and warrants		224		367		249		462

		20,546		20,556		20,551		20,485

7.	Inventories:

Inventories consist of the following:

(In thousands)	September 30, 2006		December 31, 2005

Raw materials and component parts	$	29,531	$	19,529
Finished goods		41,464		29,102

	$	70,995	$	48,631

8.	Long-term Debt:

In July 2004, Inter Parfums, S.A. entered into a €16 million five-year credit agreement. The long-term credit facility, which bears interest at 0.60% above the three month EURIBOR rate, provides for principal to be repaid in 20 equal quarterly installments and requires the maintenance of a debt equity ratio of less than one. At the September 30, 2006 exchange rate, maturities of long-term debt subsequent to September 30, 2006 are $1.0 million in 2006, $4.1 million in 2007 and 2008, and $2.0 million in 2009.

In order to reduce exposure to rising variable interest rates, the Company entered into a swap transaction effectively exchanging the variable interest rate referred to above to a variable rate based on the 12 month EURIBOR rate with a floor of 3.25% and a ceiling of 3.85%. This derivative instrument is recorded at fair value and changes in fair value are reflected in the consolidated statements of income.

Page 10

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

9.	Entry into Material Definitive Agreements:

In March 2006, we entered into an exclusive worldwide license agreement with Quiksilver, Inc. for the creation, development and distribution of fragrance, suncare, skincare and related products under the Roxy brand and suncare and related products under the Quiksilver brand. The agreement, which runs through 2017, requires advertising expenditures and royalty payments in line with industry practice. Our plans call for the first new product line under the agreement, a Roxy fragrance family, to be introduced in late 2007, followed by a Quiksilver suncare line.

In September 2006, we entered into an exclusive, worldwide license agreement with Van Cleef & Arpels Logistics SA, for the creation, development and distribution of fragrance and related bath and body products under the Van Cleef & Arpels brand and related trademarks. The agreement runs through December 31, 2018, and each party has the right to extend the term for five years on or before June 1, 2018 if certain sales targets are met in year 2017. Our rights under such license agreement are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. As an inducement to enter into this license agreement, we agreed to pay €18 million (approximately $22.5 million) to Van Cleef & Arpels Logistics SA in a lump sum, up front royalty payment, and we agreed to purchase the existing inventory of approximately $4.0 million held by YSL Beauté, the current licensee. The liability for the €18 million up front payment is included in accrued expenses on the accompanying balance sheet as of September 30, 2006. The license agreement will become effective on January 1, 2007, subject to the purchase of the inventory which we anticipate will occur in January 2007.

Page 11

INTER PARFUMS, INC. AND SUBSIDIARIES

Item 2:

MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward Looking Information

Statements in this report which are not historical in nature are forward-looking statements. Although we believe that our plans, intentions and expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such plans, intentions or expectations will be achieved. In some cases you can identify forward-looking statements by forward-looking words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," "will" and "would" or similar words. You should not rely on forward-looking statements because actual events or results may differ materially from those indicated by these forward-looking statements as a result of a number of important factors. These factors include, but are not limited to, the risks and uncertainties discussed under the headings “Forward Looking Statements” and "Risk Factors" in Inter Parfums' annual report on Form 10-K for the fiscal year ended December 31, 2005, and the reports Inter Parfums files from time to time with the Securities and Exchange Commission. Inter Parfums does not intend to and undertakes no duty to update the information contained in this report.

Overview

We operate in the fragrance and cosmetic industry, and manufacture, market and distribute a wide array of fragrances, cosmetics and health and beauty aids. We manage our business in two segments, European based operations and United States based operations. We specialize in prestige, specialty retail, and mass-market perfumes, cosmetics and other personal care products. Practically all of our prestige products are produced and marketed by our 73% owned subsidiary in Paris, Inter Parfums, S.A., which is also a publicly traded company as 27% of Inter Parfums, S.A. shares trade on the Euronext. Prestige cosmetics and prestige skin care products represent less than 5% of consolidated net sales. Our specialty retail and mass-market products are produced and marketed by our United States operations.

Our prestige product lines, which are manufactured and distributed by us primarily under license agreements with brand owners, represented approximately 86% of net sales for the nine months ended September 30, 2006. We have built a portfolio of brands, which includes Burberry, Lanvin, Paul Smith, S.T. Dupont, Christian Lacroix, Nickel, Diane von Furstenberg, Quiksilver/Roxy and Van Cleef & Arpels whose products are distributed in over 120 countries around the world. Burberry is our most significant license; sales of Burberry products represented 59% of net sales for the nine month period ended September 30, 2006.

Our mass-market and specialty retail product lines, which are marketed through our United States operations represented 14% of sales for the nine months ended September 30, 2006, and are comprised of fragrances, cosmetics, health and beauty aids and personal care products. Mass market products are sold under trademarks owned by us or pursuant to license agreements we have for the trademarks Jordache and Tatiana. Our specialty retail products consist of products developed for Gap, Gap Outlet, Banana Republic and Banana Republic Factory Stores, North American stores.

Page 12

INTER PARFUMS, INC. AND SUBSIDIARIES

We grow our business in two distinct ways. First, we grow by adding new brands to our portfolio, either through new licenses, ventures or out-right acquisitions of brands. Second, we grow through the creation of product line extensions within the existing brands in our portfolio. Every two to three years, we create a new family of fragrances for each prestige brand in our portfolio and new product development for our specialty retail and mass market product lines is ongoing.

Our business is not very capital intensive, and it is important to note that we do not own any manufacturing facilities. Rather, we act as a general contractor and source needed components from our suppliers. These components are received at one of our distribution centers and then, based upon production needs, the components are sent to one of several outside fillers which manufacture the finished good for us and ship it back to our distribution center.

Recent Important Events

Van Cleef & Arpels

As an inducement to enter into this license agreement we agreed to pay €18 million (approximately $22.5 million) to Van Cleef & Arpels Logistics SA in a lump sum, up front royalty payment, and we agreed to purchase the existing inventory held by YSL Beauté, the current licensee. The license agreement will become effective on January 1, 2007, subject to the purchase of the inventory which we anticipate will occur in January 2007.

Quiksilver/Roxy

The Roxy and Quiksilver names are hugely popular in the global youth market and are synonymous with the heritage and culture of surfing, skateboarding and snowboarding. Our goal is to leverage the passion and loyalty of the Roxy and Quiksilver brands as we bring their customers exciting new products. Our plans call for the first new product line under the agreement, a Roxy fragrance family, to be introduced in late 2007, followed by a Quiksilver suncare line.

Gap and Banana Republic

On July 14, 2005, we entered into an exclusive agreement with Gap, Inc. to develop, produce, manufacture and distribute personal care and home fragrance products for Gap and Banana Republic brand names to be sold in Gap and Banana Republic retail stores in the United States and Canada. On March 2, 2006, the agreement was amended to include Gap Outlet and Banana Republic Factory Stores in the United States and Canada. This agreement marks our entrée into the specialty retail store fragrance business.

Page 13

INTER PARFUMS, INC. AND SUBSIDIARIES

The Banana Republic Discover Collection, a line of five fragrances was launched at Banana Republic’s North American stores in September 2006. The collection consists of three scents for women and two for men, each named after a luxurious, natural material that is both emotional and authentic. In addition, a full line of bath and body products as well as home fragrance products were created to complement the fragrance selection. A separate line of fragrance and personal care products is also in the works for Gap’s North American stores. That line is expected to launch in 2007.

Discussion of Critical Accounting Policies

We make estimates and assumptions in the preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ significantly from those estimates under different assumptions and conditions. We believe the following discussion addresses our most critical accounting policies, which are those that are most important to the portrayal of our financial condition and results of operations. These accounting policies generally require our management's most difficult and subjective judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. The following is a brief discussion of the more critical accounting policies that we employ.

Revenue Recognition

We sell our products to department stores, perfumeries, specialty retailers, mass-market retailers, supermarkets and domestic and international wholesalers and distributors. Sales of such products by our domestic subsidiaries are denominated in U.S. dollars and sales of such products by our foreign subsidiaries are primarily denominated in either Euros or U.S. dollars. Accounts receivable reflect the granting of credit to these customers. We generally grant credit based upon our analysis of the customer's financial position as well as previously established buying patterns. Generally, we do not bill customers for shipping and handling costs and all shipping and handling costs, which aggregated $3.5 million and $3.2 million for the nine month periods ended September 30, 2006 and 2005, respectively, are included in selling, general and administrative expense in the consolidated statements of income. We recognize revenues when merchandise is shipped and the risk of loss passes to the customer. Net sales are comprised of gross revenues less returns, and trade discounts and allowances.

Sales Returns

Generally, we do not permit customers to return their unsold products. However, on a case-by-case basis we occasionally allow customer returns. We regularly review and revise, as deemed necessary, our estimate of reserves for future sales returns based primarily upon historic trends and relevant current data. We record estimated reserves for sales returns as a reduction of sales, cost of sales and accounts receivable. Returned products are recorded as inventories and are valued based upon estimated realizable value. The physical condition and marketability of returned products are the major factors we consider in estimating realizable value. Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably, from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations.

Page 14

INTER PARFUMS, INC. AND SUBSIDIARIES

Promotional Allowances

We have various performance-based arrangements with certain retailers to reimburse them for all or a portion of their promotional activities related to our products. These arrangements primarily allow customers to take deductions against amounts owed to us for product purchases. Estimated accruals for promotions and co-operative advertising programs are recorded in the period in which the related revenue is recognized. We review and revise the estimated accruals for the projected costs for these promotions. Actual costs incurred may differ significantly, either favorably or unfavorably, from estimates if factors such as the level and success of the retailers' programs or other conditions differ from our expectations.

Inventories

Inventories are stated at the lower of cost or market value. Cost is principally determined by the first-in, first-out method. We record adjustments to the cost of inventories based upon our sales forecast and the physical condition of the inventories. These adjustments are estimates, which could vary significantly, either favorably or unfavorably, from actual requirements if future economic conditions or competitive conditions differ from our expectations.

Equipment and Other Long-Lived Assets

Equipment, which includes tools and molds, is recorded at cost and is depreciated on a straight-line basis over the estimated useful lives of such assets. Changes in circumstances such as technological advances, changes to our business model or changes in our capital spending strategy can result in the actual useful lives differing from our estimates. In those cases where we determine that the useful life of equipment should be shortened, we would depreciate the net book value in excess of the salvage value, over its revised remaining useful life, thereby increasing depreciation expense. Factors such as changes in the planned use of equipment, or market acceptance of products, could result in shortened useful lives.

Long-lived assets, including trademarks, licenses, goodwill and other rights, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of any such asset may not be recoverable. If the sum of the undiscounted cash flows (excluding interest) is less than the carrying value, then we recognize an impairment loss, measured as the amount by which the carrying value exceeds the fair value of the asset. The estimate of undiscounted cash flow is based upon, among other things, certain assumptions about expected future operating performance. Our estimates of undiscounted cash flow may differ from actual cash flow due to, among other things, economic conditions, changes to our business model or changes in consumer acceptance of our products. In those cases where we determine that the useful life of other long-lived assets should be shortened, we would amortize the net book value in excess of the residual value (after testing for impairment as described above), over the revised remaining useful life of such asset thereby increasing amortization expense.

Page 15

INTER PARFUMS, INC. AND SUBSIDIARIES

Results of Operations

Three and Nine Months Ended September 30, 2006 as Compared to the Three and Nine Months Ended September 30, 2005

Net Sales

	Three months ended September 30,							Nine months ended September 30,
	2006		2005		% Change			2006		2005		% Change
	(in millions)

European based product sales	$	76.1	$	67.1		13	%	$	199.7	$	181.8		10	%
United States based product sales		13.6		8.3		64	%		31.2		26.1		20	%
	$	89.7	$	75.4		19	%	$	230.9	$	207.9		11	%

Net sales for the three months ended September 30, 2006 increased 19% to $89.7 million, as compared to $75.4 million for the corresponding period of the prior year. At comparable foreign currency exchange rates, net sales increased 13% for the period.

Net sales for the nine months ended September 30, 2006 increased 11% to $230.9 million, as compared to $207.9 million for the corresponding period of the prior year. At comparable foreign currency exchange rates, net sales also increase 11% for the period.

European based prestige product sales increased 13% for the three months ended September 30, 2006 and 10% for the nine months ended September 30, 2006, as compared to the corresponding periods of the prior year. Contributing to the sales growth was the debut of Lanvin Rumeur and solid gains made by Éclat d’Arpège, which has been a strong seller since its introduction in 2002. In local currency, Lanvin fragrance sales were up 56% and 23% for the three and nine month periods ended September 30, 2006, respectively, as compared to the corresponding periods of the prior year.

Increased Burberry sales, reflecting the successful launch and rollout of the Burberry London fragrance family with only a modest decline by other fragrances within the brand also contributed to the European based prestige product sales increase. In local currency, Burberry fragrance sales were up 5% and 9% for the three and nine month periods ended September 30, 2006, respectively, as compared to the corresponding periods of the prior year.

The final quarter of 2006 will include the launch of the men’s fragrance, Paul Smith Story and plans for 2007 include women’s fragrances for S.T. Dupont, Christian Lacroix and our first Roxy fragrance.

With respect to our United States based specialty retail and mass-market product lines, net sales were up 64% and 20% for the three and nine month periods ended September 30, 2006, respectively, as compared to the corresponding periods of the prior year. The sales gains are primarily the effect of having commenced, in early 2006, shipments to Gap, Gap Outlet, Banana Republic and Banana Republic Factory Stores, their existing lines of fragrance and personal care products. For the three month period ended September 30, 2006, the sales increase also reflects the launch of the Banana Republic Discover Collection, a line of five fragrances which debuted in Banana Republic’s North American stores in September. The collection consists of three scents for women and two for men, each named after a luxurious, natural material that is both emotional and authentic. In addition, a full line of bath and body products as well as home fragrance products were created to complement the fragrance selection. A separate line of fragrance and personal care products is also in the works for Gap’s North American stores. That line is expected to launch in early 2007.

Page 16

INTER PARFUMS, INC. AND SUBSIDIARIES

In accordance with our agreement with Gap, Inc., we have established a dedicated operating unit and have begun staffing it. Eventually this unit will employ in excess of 25 people. We have incurred and expect to continue to incur staffing, product development and other start-up expenses, including those of third-party design and marketing firms. To propel these programs forward, these expenses are expected to continue throughout the balance of 2006 and early 2007. In addition, we have transitioned component sourcing and production of Gap, Inc.’s existing fragrance and personal care product lines to suppliers and contract fillers of the Company. Margins on sales to Gap, Inc. of their existing product lines are minimal, as we are honoring all existing purchase commitments.

In March 2006, we entered into an exclusive worldwide license agreement with Quiksilver, Inc. for the creation, development and distribution of fragrance, suncare, skincare and related products under the Roxy brand and suncare and related products under the Quiksilver brand. The Roxy and Quiksilver names are hugely popular in the global youth market and are synonymous with the heritage and culture of surfing, skateboarding and snowboarding. Our goal is to leverage the passion and loyalty of the Roxy and Quiksilver brands as we bring their customers exciting new products. Our plans call for the first new product line under the agreement, a Roxy fragrance family, to be introduced in late 2007, followed by a Quiksilver suncare line.

In addition, we are actively pursuing other new business opportunities. However, we cannot assure you that any new license or acquisitions will be consummated.

Gross Margins

		Three months ended September 30,						Nine months ended September 30,
		2006			2005			2006			2005
		(in millions)
Net sales	$	89.7		$	75.5		$	230.9		$	207.9
Cost of sales		41.0			33.1			102.2			90.4
Gross margin	$	48.7		$	42.4		$	128.7		$	117.5
Gross margin as a percent of net sales		54	%		56	%		56	%		57	%

Gross profit margin was 54% and 56% for the three and nine month periods ended September 30, 2006, respectively, as compare to 56% and 57% for the corresponding periods of the prior year. The gross margin decline in 2006 is the result of increased sales of lower margin United States product lines and increased point of purchase promotional activities in 2006 to support our aggressive 2006 prestige fragrance launch schedule.

Page 17

INTER PARFUMS, INC. AND SUBSIDIARIES

As previously reported, in anticipation of the new terms of the Burberry license, and to mitigate the associated expenses, we fine-tuned our operating model. This new model, which was put into effect as of the beginning of 2005, included increased selling prices to distributors, modified cost sharing arrangements with suppliers and distributors, and will involve the future formation of joint ventures or Company-owned subsidiaries in the United Kingdom, Germany, Italy and Spain, to handle future distribution. Until we begin operations with our own distribution subsidiaries or joint ventures planned for January 2007, we expect gross margins to remain relatively steady.

Selling, General & Administrative Expense


		Three months ended September 30,						Nine months ended September 30,
		2006			2005			2006			2005
		(in millions)
Selling, general & administrative	$	39.3		$	35.1		$	103.7		$	94.3
Selling, general & administrative as a percent of net sales		44	%		47	%		45	%		45	%

Selling, general and administrative expense increased 12% and 10% for the three and nine-month periods ended September 30, 2006, respectively, as compared to the corresponding periods of the prior year. As a percentage of sales, selling, general and administrative expense was 44% and 45% of sales for the three and nine-month periods ended September 30, 2006, respectively, as compared to 47% and 45% for the corresponding periods of the prior year.

In connection with our agreement with Gap, Inc., we continue to incur staff, product development and other start-up expenses, including those of third-party design and marketing firms. For the three and nine month periods ended September 30, 2006, such expenses aggregated approximately $2.0 million and $5.0 million, respectively and are included in selling, general, and administrative expenses.

Increased advertising expenditure requirements and increased royalties under our new license with Burberry are now reflected in both the 2006 and 2005 periods. Higher promotional costs were incurred in connection with the Burberry London Women’s fragrance launch. Promotion and advertising included in selling, general and administrative expenses aggregated $13.1 million and $35.1 million for the three and nine-month periods ended September 30, 2006, respectively, as compared to $12.7 million and $31.7 million, respectively, for the corresponding periods of the prior year. Royalty expense, included in selling, general, and administrative expenses, aggregated $10.4 million and $23.4 million for the three and nine-month periods ended September 30, 2006, respectively, as compared to $8.8 million and $23.6 million, respectively, for the corresponding periods of the prior year. In September 2006, the license with Burberry was amended to, among other matters, simplify the method of calculating royalty payments beginning January 1, 2006. In markets where distributors are used, the royalty payment is now based on our ex-factory sales rather than the former method based on our distributor’s wholesale sales to retailers. The estimated impact of this change was an increase to royalty expense by approximately $1.5 million for the three months ended September 30, 2006.

Page 18

INTER PARFUMS, INC. AND SUBSIDIARIES

As a result of the details discussed above with respect to gross margin and selling, general and administrative expenses, income from operations increased 7.5% or $1.7 million for the nine-month period ended September 30, 2006, as compared to the corresponding period of the prior year. Operating margins were 11.0% of net sales for both nine-month periods ended September 30, 2006 and 2005.

Interest expense aggregated $0.3 million and $0.8 million for the three and nine-month periods ended September 30, 2006, respectively, as compared to $0.1 million and $0.7 million for the corresponding periods of the prior year. We use short-term borrowings from credit lines available to us, as needed, to finance our working capital requirements.

Foreign currency gains aggregated $0.1 million and $0.4 million for the three and nine-month periods ended September 30, 2006, respectively, as compared to $0.1 million for both the three and nine-month periods ended September 30, 2005. We enter into foreign currency forward exchange contracts to manage exposure related to certain foreign currency commitments.

Our effective income tax rate was 34% for both the three and nine-month periods ended September 30, 2006, as compared to 34% and 36%, respectively, for the corresponding periods of the prior year. For the nine-month period ended September 30, 2006, tax benefits, including state and local tax benefits, from losses in the United States are at higher effective rates than taxes on foreign profits, resulting in a slightly lower overall effective tax rate. No significant changes in tax rates were experienced nor are any expected in jurisdictions where we operate.

Net income increased 24% to $4.6 million for the three months ended September 30, 2006, as compared to $3.8 million for the corresponding period of the prior year. Net income increased 8% to $12.3 million for the nine months ended September 30, 2006, as compared to $11.4 million for the corresponding period of the prior year.

Diluted earnings per share increased 28% to $0.23 for the three months ended September 30, 2006, as compared to $0.18 for the corresponding period of the prior year. Diluted earnings per share increased 7% to $0.60 for the nine months ended September 30, 2006, as compared to $0.56 for the corresponding period of the prior year.

Weighted average shares outstanding aggregated 20.3 million for both the three and nine-month periods ended September 30, 2006, as compared to 20.2 million and 20.0 million for the corresponding periods of the prior year. On a diluted basis, average shares outstanding were 20.5 million and 20.6 million for the three and nine-month periods ended September 30, 2006, respectively, as compared to 20.6 million and 20.5 million for the corresponding periods of the prior year.

Page 19

INTER PARFUMS, INC. AND SUBSIDIARIES

Liquidity and Financed Resources

Our financial position remains strong. At September 30, 2006, working capital aggregated $127 million and we had a working capital ratio in excess of 2 to 1. Cash and cash equivalents and short-term investments aggregated $54 million.

In July 2004, Inter Parfums, S.A. entered into a €16 million, five-year credit agreement. In order to reduce exposure to rising variable interest rates, Inter Parfums, S.A. entered into a swap transaction effectively exchanging a three-month variable interest rate to a variable rate based on the 12 month EURIBOR rate with a floor of 3.25% and a ceiling of 3.85%. This derivative instrument is recorded at fair value and changes in fair value are reflected in the accompanying consolidated statements of income.

In April 2004, Inter Parfums, S.A. acquired a 67.5% interest in Nickel for approximately $4.5 million, net of cash acquired. We funded this acquisition with cash on hand. In accordance with the purchase agreement, each of the minority shareholders has an option to put their remaining interest in Nickel to Inter Parfums, S.A. from January 2007 through June 2007. Based on an independent valuation, management had valued the put options as of the date of acquisition. These options are carried at fair value as determined by management.

The purchase price for the minority shares will be based upon a formula applied to Nickel’s sales for the year ending December 31, 2006, pro rated for the minority holders’ equity in Nickel or at a price approximately 7% above the April 2004 purchase price.

Cash used in operating activities aggregated $6.6 million for the nine months ended September 30, 2006 as compared to $7.7 million of cash that was provided by operating activities for the nine months ended September 30, 2005. At September 30, 2006, cash flows used-in operating activities shows inventories increased 40% from December 31, 2005. Inventories were at an unusually low level as of December 31, 2005 as no major new product launches were on the calendar. Our 2006 new prestige product calendar has been very ambitious, with launches of new fragrance families for our three largest prestige brands. In addition, an inventory buildup was required for new products created for the September launch at Banana Republic’s North American stores as well as the transitioning of component sourcing and production of Gap, Inc.’s existing fragrance and personal care product lines to suppliers and contract fillers of the Company.

For the nine months ended September 30, 2006, cash flows used-in operating activities shows that accounts receivable increased 28% from the December 31, 2005 balance while sales were up 20% during the same period. Our holiday selling season begins in June and runs through October and it is not unusual to see a significant increase as of the end of the third quarter and its reversal during the fourth quarter.

Page 20

INTER PARFUMS, INC. AND SUBSIDIARIES

Cash flows from investing activities, reflect proceeds from the sale of short-term investments, approximately $4.1 million in payments for intangible assets and approximately $2.8 million in capital expenditures. Our business is not capital intensive as we do not own any manufacturing facilities. We typically spend between $2.0 and $3.0 million per year on tools and molds, depending on our new product development calendar. The balance of capital expenditures is for office fixtures, computer equipment and industrial equipment needed at our distribution centers. Capital expenditures in 2006 are expected to be in the range of $3.5 million to $4.5 million, as a result of our ambitious launch schedule and the planned renovation of our United States corporate offices. Cash flows from investing activities also reflect the sale of the Molyneux trademark in June 2006. Such sale brought in proceeds of $0.9 million and resulted in a loss of $0.2 million.

In March 2006, our board of directors approved the continuation of our cash dividend of $.16 per share, approximately $3.3 million per annum, payable $.04 per share on a quarterly basis. Our next cash dividend of $.04 per share will be paid on January 15, 2007 to shareholders of record on December 29, 2006. Dividends paid, including dividends paid once per year to minority shareholders of Inter Parfums, S.A., aggregated $3.7 million and $3.3 million for the nine-month periods ended September 30, 2006 and 2005, respectively. The cash dividend in 2006 represents a small part of our overall cash position and is not expected to have any significant impact on our financial position.

Our short-term financing requirements are expected to be met by available cash at September 30, 2006, cash generated by operations and short-term credit lines provided by domestic and foreign banks. The principal credit facilities for 2006 consist of a $12.0 million unsecured revolving line of credit provided by a domestic commercial bank and approximately $45.0 million in credit lines provided by a consortium of international financial institutions. Generally, actual borrowings under these facilities have been minimal as we typically use our working capital to finance all of our cash needs. However, as of September 30, 2006, we are using $10.2 million of our credit lines to finance working capital needs of our 2006 new product launches.

We believe that funds generated from operations, supplemented by our present cash position and available credit facilities, will provide us with sufficient resources to meet all present and reasonably foreseeable future operating needs.

Inflation rates in the U.S. and foreign countries in which we operate did not have a significant impact on operating results for the period ended September 30, 2006.

Contractual Obligations

We lease our office and warehouse facilities under operating leases expiring through 2013. Obligations pursuant to these leases for the years ended December 31, 2006, 2007, 2008, 2009, 2010 and thereafter are $5.5 million, $5.5 million, $5.6 million, $5.7 million, $5.5 million and $6.6 million, respectively.

We are obligated under a number of license agreements for the use of trademarks and rights in connection with the manufacture and sale of our products. Obligations pursuant to these license agreements for the years ended December 31, 2006, 2007, 2008, 2009, 2010 and thereafter are $24.0 million, $26.6 million, $26.9 million, $28.0 million, $28.1 million and $184.6 million, respectively.

Page 21

INTER PARFUMS, INC. AND SUBSIDIARIES

Item 3:

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

General

We address certain financial exposures through a controlled program of risk management that primarily consists of the use of derivative financial instruments. Our French subsidiary primarily enters into foreign currency forward exchange contracts in order to reduce the effects of fluctuating foreign currency exchange rates. We do not engage in the trading of foreign currency forward exchange contracts or interest rate swaps.

Foreign Exchange Risk Management

We periodically enter into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and to manage risks related to future sales expected to be denominated in a foreign currency. We enter into these exchange contracts for periods consistent with our identified exposures. The purpose of the hedging activities is to minimize the effect of foreign exchange rate movements on the receivables and cash flows of Inter Parfums, S.A., our French subsidiary, whose functional currency is the Euro. All foreign currency contracts are denominated in currencies of major industrial countries and are with large financial institutions, which are rated as strong investment grade.

All derivative instruments are required to be reflected as either assets or liabilities in the balance sheet measured at fair value. Generally, increases or decreases in fair value of derivative instruments will be recognized as gains or losses in earnings in the period of change. If the derivative is designated and qualifies as a cash flow hedge, the changes in fair value of the derivative instrument will be recorded in other comprehensive income.

Before entering into a derivative transaction for hedging purposes, we determine that the change in the value of the derivative will effectively offset the change in the fair value of the hedged item from a movement in foreign currency rates. Then, we measure the effectiveness of each hedge throughout the hedged period. Any hedge ineffectiveness is recognized in the income statement.

We believe that our risk of loss as the result of nonperformance by any of such financial institutions is remote and in any event would not be material. The contracts have varying maturities with none exceeding one year. Costs associated with entering into such contracts have not been material to our financial results. At September 30, 2006, we had foreign currency contracts in the form of forward exchange contracts in the amount of approximately U.S. $44.6 million and GB Pounds 8.1 million.

Page 22

INTER PARFUMS, INC. AND SUBSIDIARIES

Interest Rate Risk Management

We mitigate interest rate risk by continually monitoring interest rates, and then determining whether fixed interest rates should be swapped for floating rate debt, or if floating rate debt should be swapped for fixed rate debt. We have entered into one (1) interest rate swap to reduce exposure to rising variable interest rates, by effectively exchanging the variable interest rate of 0.6% above the three month EURIBOR rate on our long-term to a variable rate based on the 12 month EURIBOR rate with a floor of 3.25% and a ceiling of 3.85%. This derivative instrument is recorded at fair value and changes in fair value are reflected in the accompanying consolidated statements of income.

Item 4.

CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer and Chief Financial Officer have reviewed and evaluated the effectiveness of our disclosure controls and procedures (as defined in the Securities Exchange Act of 1934 Rule 13a-14(c)) as of the end of the period covered by this quarterly report on Form 10-Q (the “Evaluation Date”). Based on their review and evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of the Evaluation Date, our Company's disclosure controls and procedures were adequate and effective to ensure that material information relating to our Company and its consolidated subsidiaries would be made known to them by others within those entities, so that such material information is recorded, processed and reported in a timely manner, particularly during the period in which this quarterly report on Form 10-Q was being prepared, and that no changes were required at this time.

Changes in Internal Controls

There has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during the quarterly period covered by this report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

Part II. Other Information

Items 1, 1A, 2, 3, 4 and 5 are omitted as they are either not applicable or have been included in Part II.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

In accordance with the provisions of our agreement with The Gap, Inc. (“Gap”), on September 1, 2006, we granted to Gap a warrant to purchase 100,000 shares of our common stock exercisable for five years at $17.194 and have also agreed to register with the Securities and Exchange Commission the shares purchasable thereunder for resale after January 1, 2007. The grant was exempt from the registration requirements of Section 5 of the Securities Act under Sections 4(2) and 4(6) of the Securities Act. Pending the effective date of such registration statement, Gap has agreed that, if the warrant is exercised, then Gap would purchase the shares of common stock for investment and not with a view towards resale to the public.

Page 23

INTER PARFUMS, INC. AND SUBSIDIARIES

Item 6. Exhibits.

The following document is filed herewith:

Exhibit No.	Description

10.128	License Agreement Between Van Cleef & Arpels Logistics SA, And Inter Parfums, S.A., entered into on June 19, 2006 (Certain confidential information in this Exhibit 10.128 was omitted and filed separately with the Securities and Exchange Commission with a request for confidential treatment by Inter Parfums, Inc).

10.128.1	Addendum No. 1 to License Agreement Between Van Cleef & Arpels Logistics SA, And Inter Parfums, S.A

31.1	Certifications required by Rule 13a-14(a) of Chief Executive Officer

31.2	Certifications required by Rule 13a-14(a) of Chief Financial Officer

32	Certification required by Section 906 of the Sarbanes-Oxley Act

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on the 7th day of November 2006.

		INTER PARFUMS, INC.


	By:	/s/ Russell Greenberg
		Executive Vice President and
		Chief Financial Officer

Page 24

LICENSE AGREEMENT

VAN CLEEF & ARPELS

AND

INTER PARFUMS

Exhibit 10.128: Certain confidential information in this Exhibit 10.128 was omitted and filed separately with the Securities and Exchange Commission (“SEC”) with a request for confidential treatment by Inter Parfums, Inc.

CONTENTS		PAGE

1.	DEFINITIONS	2
2.	LICENSE	5
3.	COMPENSATION TO LICENSOR	6
4.	PRODUCTS AND QUALITY CONTROL	9
5.	MARKETING AND LAUNCH PLANS, ADVERTISING, MARKETING AND SALES PROMOTION	12
6.	DISTRIBUTION	16
7.	TERM AND TERMINATION	17
8.	TRADEMARKS AND OTHER INTELLECTUAL PROPERTY RIGHTS	21
9.	EXCLUSIVITY	25
10.	PRODUCT LIABILITY	25
11.	CONFIDENTIALITY	26
12.	NOTICES	29
13.	ASSIGNMENT	29
14.	ENTIRE AGREEMENT, MODIFICATION	30
15.	APPLICABLE LAW, JURISDICTION	31
16.	REMEDIES, NO WAIVER	31
17.	SEVERABILITY	32
18.	SECTION HEADINGS	32
19.	FORCE MAJEURE	32

Annex A	Trademarks
Annex B	Quality Criteria
Annex C	Form of Royalty Report
Annex D	Marketing Activities
Annex E	Selective Distribution Criteria
Annex F	Annual Marketing Plan
Annex G	KEY MARKETS

LICENSE AGREEMENT

between

VAN CLEEF & ARPELS LOGISTICS SA,

a company incorporated under the laws of Switzerland, having its registered office at 8, route de Chandolan, 1752 Villars-sur-Glâne, Switzerland

hereinafter referred to as “LICENSOR”

and

INTER PARFUMS SA,

a company incorporated under the laws of France RCS Paris B 350 219 382 , having its registered office at 4 rond-point des Champs Elysée 75008 PARIS, France

hereafter referred to as “LICENSEE”

WHEREAS, LICENSOR and/or its RELATED COMPANIES (as hereinafter defined) are the owners of the TRADEMARKS (as hereinafter defined), the tradename “Van Cleef & Arpels” (hereinafter “TRADENAME”), and the goodwill and reputation associated with them and manufactures or has manufactured for it and sells under the TRADEMARKS luxury goods, in particular high quality jewellery and watches.

WHEREAS, LICENSOR has the right to grant the exclusive right to use the TRADEMARKS and the TRADENAME in connection with the marketing of luxury fragrance and cosmetic products throughout the world in accordance with the terms and conditions of this AGREEMENT and to grant a license for the use of the TRADEMARKS as provided herein.

WHEREAS, LICENSEE desires to obtain the right to use the TRADEMARKS and the TRADENAME on and in connection with the development, manufacture and sale of the PRODUCTS (as hereinafter defined) throughout the world in accordance with the terms and conditions of this AGREEMENT.

WHEREAS, LICENSOR is willing to grant LICENSEE the right to use the TRADEMARKS and the TRADENAME on and/or in connection with the manufacture and sale of the PRODUCTS (as hereinafter defined) throughout the TERRITORY on the terms and conditions hereinafter provided.

LICENSEE is informed of the current licence agreement for Products under the Trademarks (both as hereinafter defined) with YSL Beauté and the parties agree that this Agreement shall only enter into force if and when the current licence agreement with YSL Beauté will have been terminated and the terms of Section 3.1, 7.1 and 20 has been agreed on in writing. It is further agreed by the parties that this Agreement shall not enter into force and be nul and void if no termination Agreement is reached with the current licensee with effect as per September 30, 2006.

THEREFORE, in consideration of the said premises and the mutual promises and covenants contained herein, the parties agree as follows:

1. DEFINITIONS

Unless the context otherwise requires, the following terms shall have the following meanings:

1.1	“AGREEMENT” shall mean this License Agreement including all Annexes and Exhibits hereto, as the same may be amended, supplemented or modified in accordance with Section 14 hereof;

1.2	“COMMENCEMENT DATE” shall mean the date on which the termination of LICENSOR’S current licence agreement for PRODUCTS under the TRADEMARKS is effective, which has to be a date on or prior to September 30, 2006.

1.3	“CONTRACTUAL YEAR” shall mean the period commencing on the COMMENCEMENT DATE and ending December 31, 2007 and thereafter any subsequent period of twelve months commencing on January 1 and ending on the following December 31;

1.4

“TRADEMARKS” shall mean the trademark “Van Cleef & Arpels” and other trademarks as represented and listed in Annex A Part 1 and 2 hereto, together with any further names, symbols or marks which the parties may agree to introduce in accordance with the provisions of this AGREEMENT for the purpose of applying to the PRODUCTS, and shall include (but not be limited to) the various registrations thereof which have been obtained, which are pending, or which may be obtained, as are relevant to the PRODUCTS;

1.5	“BOTTLES” shall mean the bottles or other containers (including, but without limitation, tubes, vials, jars, etc.) for the PRODUCTS in which the PRODUCTS are sold;

1.6	“FORMULAE” shall mean the formulae relevant to the PRODUCTS, including but not limited the formula of the scent of the PRODUCTS;

-2-

1.7	“PRESENTATION” shall mean all trademarks, get-up, designs, advertising, merchandising, point of sale, promotional and packaging (including labelling) material appearing upon or used in relation to the PRODUCTS;

1.8

“PRODUCTS” shall mean such luxury fragrance (women’s and men’s fragrance and home fragrance) and cosmetic products (limited to bath and body products, to the exclusion of skin care and make up products) as shall be launched in accordance with the provisions of this AGREEMENT, that LICENSEE may market, distribute and sell in connection with the TRADEMARKS and/or the TRADENAME pursuant to the terms and conditions of this AGREEMENT;

1.9

“TECHNICAL INFORMATION” shall mean any and all know-how and retail information in connection with, for example, creative and technical input with respect to design, image, corporate identity, brand direction, advertising, marketing and promotion (including LICENSOR’S global marketing policy) relating to the PRODUCTS;

1.10	“QUALITY CRITERIA” shall mean the quality criteria as outlined in Annex B attached hereto which may be amended with both parties’ written agreement (Section 14.2 below) and shall be consistent with the prestige of the TRADEMARKS, the TRADENAME and the goodwill and reputation associated with them;

1.11

“BEST LOCAL WHOLESALE PRICE” shall, for the purpose of Section 6.5 below mean the lowest price of the first sale of the PRODUCTS from LICENSEE or a RELATED COMPANY of LICENSEE to any third party which is not a RELATED COMPANY of LICENSEE, may that be a distributor or a retailer, in each relevant market;

1.12	“LICENSOR’S OUTLETS” shall mean those shop-in-shops, corners, concessions and free standing boutiques which are owned, operated or managed by LICENSOR, by any of its RELATED COMPANIES and/or by a third party under the TRADENAME;

1.13	“TERRITORY” shall mean all countries and territories throughout the world, including duty free zones;

1.14

“NET SALES” shall mean the invoice prices invoiced by LICENSEE and any of its RELATED COMPANIES on the first sale of PRODUCTS in the ordinary course of business to a non-RELATED COMPANY, after deduction of any sales taxes imposed on LICENSEE directly in respect of the PRODUCTS, credits, product returns, trade or cash discounts (including year-end discounts), provided that the aggregate of such deductions shall not exceed such amount as would be normal business practice in relation to the sale of luxury fragrance and grooming products of comparable prestige and price to the PRODUCTS. For the avoidance of any doubt, NET SALES shall not include sales of point of sales and/or promotional materials, including but not limited to testers, minis, samples, show cards and windows.

-3-

1.15	“RELATED COMPANIES” shall mean any parent or subsidiary of any of the parties or any company affiliated with or related to any of them or a party or any company under common control with any of them;

1.16	“KEY MARKETS” shall mean the territories listed in Annex G .

1.17	“PROJECTED NET SALES” shall mean the projected net sales figure for the PRODUCTS in any calendar year as contained in the annual marketing plan relevant for that calendar year;

-4-

2. LICENSE

2.1

LICENSOR hereby grants LICENSEE an exclusive license to use the TRADEMARKS and/or the TRADENAME in connection with the development, manufacture, sale, distribution, advertising, merchandising, promotion and marketing of the PRODUCTS in the TERRITORY for the term of the AGREEMENT in accordance with the conditions set out below. LICENSEE shall be entitled to use the TRADEMARKS set forth in Annex A Part 1 hereto and/or the TRADENAME in connection with other trademarks and/or other distinctive or descriptive attributes (words, logos, devices, etc.) but only as LICENSOR shall first approve in accordance with Section 4.2 (in particular Section 4.2.2) and as set forth below. The goodwill generated through the sale of the PRODUCTS shall vest exclusively in LICENSOR.

2.2

During the term of this AGREEMENT and subject to prior written approval by LICENSOR, LICENSEE shall also be authorised to use the TRADENAME as a branch or division name as “Parfums Van Cleef & Arpels”, especially on stationery etc., or, to incorporate the TRADENAME into the company name of a RELATED COMPANY (as “Parfums Van Cleef & Arpels”). The approval shall be deemed to have been given if LICENSOR does not give written notice of disapproval within one (1) month after LICENSOR has received LICENSEE’S written request for approval together with details of the planned incorporation of the TRADENAME.

2.3	LICENSEE will inform LICENSOR about the planned incorporation of the TRADENAME into the company name of a RELATED COMPANY in good time at the latest four weeks before the respective entry in the Commercial Register.

2.4

LICENSOR will, at the request of LICENSEE, co-operate as required in the incorporation of the TRADENAME into the company name of a RELATED COMPANY of LICENSEE, and supply all necessary declarations or take the necessary actions, the costs of such declarations or actions to be reimbursed by LICENSEE.

2.5

Promptly after the expiration or termination of the AGREEMENT, or if there is a sell-off period (Section 7.5 below) promptly after the end of such sell-off period, LICENSEE agrees to procure the change of the name of a branch, division or RELATED COMPANY referred to in Sections 2.2 to 2.4 by deleting the TRADENAME and ceasing to use and destroying all relevant headed stationary, correspondence or other printed material bearing the TRADENAME.

-5-

2.6

LICENSEE warrants that any use of the TRADENAME by a branch, division or RELATED COMPANY in accordance with the provisions of Section 2.2 above will only be permitted in order to enable LICENSEE to perform its obligations in relation to the marketing, sale, development and manufacturing of the PRODUCTS under this AGREEMENT, to the exclusion of any other activities, and will be subject to that branch, division or RELATED COMPANY complying in all other respects with the terms of this AGREEMENT and all applicable local legal requirements relating to its incorporation and the conduct of its business.

2.7

LICENSOR may only with LICENSEE’s prior written approval (which will be in LICENSEE’S exclusive discretion) and subject to the warranties given in Sections 10.2 to 10.4, be entitled to sell other products which are not PRODUCTS together with PRODUCTS, especially in combination packages, marketed under the TRADEMARK, or to give away other products as “gift with purchase” together with the PRODUCTS (hereinafter collectively called “OTHER PRODUCTS”).

3. COMPENSATION TO LICENSOR

3.1

In consideration of the rights granted and the services to be performed by LICENSOR hereunder, LICENSEE shall pay to LICENSOR a lump sum entrance fee of EUR _____* Mio. Further, in consideration of the rights granted and the services to be performed by LICENSOR during each CONTRACTUAL YEAR or part thereof a royalty which shall be equal to [--------------]¹ NET SALES of all PRODUCTS sold in any CONTRACTUAL YEAR , and which shall in any CONTRACTUAL YEAR be a minimum amount as specified in Section 3.2 below.

_______

*Left blank in original.

¹ Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc. No. 10.128:1.

-6-

3.2	LICENSEE agrees to pay the following guaranteed minimum royalties to LICENSOR to be paid in (4) equal amounts in each CONTRACTUAL YEAR (“CY”) in accordance with Section 3.3 below:

MINIMUM GUARANTEED ROYALTIES

Contractual Year	Minimum Guaranteed Royalty
CY 1 Commencement Date to Dec 31 2007	[---------------]
CY 2 Jan 1 to Dec 31 2008	[---------------]
CY 3 Jan 1 to Dec 31 2009	[---------------]
CY 4 Jan 1 to Dec 31 2010	[---------------]
CY 5 Jan 1 to Dec 31 2011	[---------------]
CY 6 Jan 1 to Dec 31 2012	[---------------]
CY 7 Jan 1 to Dec 31 2013	[---------------]
CY 8 Jan 1 to Dec 31 2014	[---------------]
CY 9 Jan 1 to Dec 31 2015	[---------------]
CY 10 Jan 1 to Dec 31 2016	[---------------]
CY 11 Jan 1 to Dec 31 2017	[---------------]
CY 12 Jan 1 to Dec 31 2018	[---------------]²

For the avoidance of doubt, the parties confirm that the minimum guaranteed royalties shall be non-cumulative on a year-to-year (CONTRACTUAL YEARS) basis.

3.3

LICENSEE shall, for each quarter of each CONTRACTUAL YEAR, pay to LICENSOR the greater of the cumulative amount of royalties payable under Section 3.1 above or the cumulative minimum royalties due in that CONTRACTUAL YEAR up to that date less any royalties, whether payable under Section 3.1 or guaranteed minimum royalty payments, already paid in that CONTRACTUAL YEAR. These payments will be made within [---------------]³after the end of each calendar quarter, such quarters ending on 31 March, 30 June, 30 September and 31 December in each CONTRACTUAL YEAR. Each payment shall be accompanied by a quarterly royalty report in the form as attached as Annex C.

² Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc. No. 10.128:2.

³ Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc. No. 10.128:3.

-7-

3.4

In addition to the quarterly royalty reports referred to in Section 3.3 above, LICENSEE shall - if requested by LICENSOR promptly after the end of a calendar year - provide to LICENSOR within [---------------]⁴of the end of each calendar year a global certificate from its internal auditors certifying that the volume and value of sales of the PRODUCTS for that calendar year and that the figures contained in the quarterly royalty reports for the same calendar year correspond with the entries in the books of LICENSEE and where appropriate, any RELATED COMPANY of LICENSEE or any other entity under its control and certifying the global deductions from gross sales made to calculate the NET SALES figure for the relevant calendar year. The certificate shall also certify that the figures set out in the year-end rebate referred to in Section 6.5 are true and accurate. Additionally, upon requested by, LICENSEE shall provide a certificate from its external auditors confirming that the volume and value of sales of the PRODUCTS for that calendar year and that the figures contained in the quarterly royalty reports correspond with the entries in the books of LICENSEE and, where appropriate, any RELATED COMPANY of LICENSEE or any other entity under its control and certifying the global deductions from gross sales made to calculate the NET SALES figure for the relevant calendar.

3.5

Failure by LICENSEE to make payment of any royalties within [--------------]⁵after their due date shall thereafter incur accrued interest at the basic bank interest rate of BNP, Banque Nationale de Paris, plus [---------------]]⁶per annum. Payment shall be applied first against any interest which may have been accrued to the date of the payment and any balance against the amount of royalties outstanding.

3.6

All taxes required by law to be withheld or assessed on or with respect to the remittance of royalties by LICENSEE or any RELATED COMPANY hereunder shall, if paid by LICENSEE or any related party, be deducted from the amount of royalties payable to LICENSOR. LICENSEE shall furnish LICENSOR with documentation reflecting the amount and proof of such tax payments.

3.7

All royalties shall be paid in Euro. The exchange rate of the royalties from foreign currencies to Euro shall be calculated according to the average rate of exchange during the last month of the quarter being reported as published in the Financial Times under the heading “Exchange Cross Rate” or, in the event that the relevant calculations cannot be made as aforesaid, by such other exchange rate calculation formula as may be agreed by the parties.

⁴ Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc. No. 10.128:4.

⁵Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc. No. 10.128:5.

⁶ Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc. No. 10.128:6.

-8-

3.8	LICENSEE shall not be obliged to pay royalties on any compensation received from its customers as a participation on advertising and sales promotion, such as payments for decoration, testers and samples.

3.9

LICENSEE agrees to keep full and accurate books and records relating to the marketing and the sale of the PRODUCTS. LICENSEE agrees that LICENSOR shall have the right to inspect, audit or make copies of the books and records of LICENSEE and/or any RELATED COMPANIES of LICENSEE relating to the computation and the payment of the royalties due and owing to LICENSOR within [--------------------]⁷after the quarter in question up to [---------------]⁸a year at reasonable times and upon no less than one month’s prior notice. This right terminates [---------------]⁹after the expiration of this AGREEMENT.

3.10

If a shortfall in the ROYALTIES paid is verified, LICENSEE shall promptly pay to LICENSOR all additional ROYALTIES due. If the shortfall is greater than [[---------------]¹⁰ of the cumulative amount of ROYALTIES paid by LICENSEE for the relevant period, then the LICENSEE shall also pay to LICENSOR an amount equal to the reasonable costs and expenses of LICENSOR’S examination together with interest calculated in accordance with Section 3.5 above.

4. PRODUCTS AND QUALITY CONTROL

4.1	The parties shall collaborate in the development process of the PRODUCTS so that the PRODUCTS brought to the market will be consistent with the image of LICENSOR and the TRADEMARKS, and in conformity with the QUALITY CRITERIA.

LICENSEE expressly agrees to take LICENSOR’S image and reputation into consideration in the development and the manufacturing of the PRODUCTS and ensure that the PRODUCTS will be in accordance with LICENSOR’S image and reputation and will not harm or diminish LICENSOR’S image and reputation and the goodwill LICENSOR has built up with its other products.

⁷ Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc. No. 10.128:7.

⁸ Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc. No. 10.128:8.

⁹ Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc. No. 10.128:9.

¹⁰ Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc. No. 10.128:10.

-9-

4.2	The parties agree that LICENSOR shall have approval rights with regard to the PRODUCTS over:

the concept

the scent

the name

the inner and outer packaging (including but not limited to the bottles, the folding boxes, any other packagings, tubes, vials and jars)

and any changes made thereto. As far advertising and marketing, it is referred to Section 5.5 below.

4.2.1

If LICENSOR does not give its approval of any of LICENSEE’S proposals with regard to the concept, the scent or the packaging, it shall give its reasons for such withholding and agrees to submit its ideas, input, advice, and suggestions with regard thereto to LICENSEE within [---------------]¹¹after having received such proposal.

4.2.2

Within [---------------]¹²of receipt of LICENSEE’S request for approval of any name in accordance with this Section 4.2, or any trademark and/or any other attribute in accordance with Section 2.1 as well as the submission of a completed availability search by LICENSEE in accordance with Section 8.16 below, LICENSOR shall notify LICENSEE which names, trademarks or attributes it approves or disapproves and shall give its reason for any disapproval.

4.2.3

In the event of non-approval pursuant to Sub-Sections 4.2.1 and/or 4.2.2 above, LICENSEE agrees to take LICENSOR’S comments, ideas, input and advice into consideration and to amend or revise its proposal and/or implement LICENSOR’S suggestions and submit the revised proposal to LICENSOR for its approval, it being understood that LICENSOR and LICENSEE shall use their best endeavours to closely cooperate in order to have finally a satisfactory common project.

4.2.4

Any proposal submitted to LICENSOR for approval and not disapproved within [---------------]¹³after LICENSOR having received such proposal shall be deemed to have been approved.

¹¹ Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc. No. 10.128:11.

¹² Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc. No. 10.128:12.

¹³Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc. No. 10.128:13.

-10-

4.3

LICENSEE shall be responsible for ensuring that the PRODUCTS, the BOTTLES, the FORMULAE and the PRESENTATION comply with the agreed designs, models and prototypes and with all relevant laws, regulations, specifications and standards in force with respect thereto and with all LICENSOR’S reasonable instructions relating to the PRODUCTS, in particular, their quality and presentation. LICENSEE will withdraw from the course of manufacture and/or storage and not place upon the market any goods found not in accordance with the QUALITY CRITERIA, whether fully or partly manufactured.

LICENSEE agrees and undertakes to maintain the quality of the PRODUCTS existing at the date of signing of this AGREEMENT at minimum at their then current level .

4.4	LICENSEE agrees to use commercially reasonable efforts to develop the sales of the PRODUCTS and to launch new PRODUCT lines at least in KEY MARKETS, as follows:

-	March 2008 : launch of new fragrance for women

-	September 2008 : launch of new fragrance for men

-	Between [---------------]¹⁴: launch of the 2^nd new fragrance for women

-	[---------------]¹⁵: animate and support of all PRODUCT lines

4.5

LICENSOR agrees to use its best efforts to ensure that the reputation, image and the goodwill of the TRADEMARKS as represented in Annex A Part 1 and/or of the TRADENAME shall retain its present standing (as of signing of this AGREEMENT), particularly in connection with other products manufactured and/or distributed under the TRADEMARKS and/or the TRADENAME by LICENSOR, RELATED COMPANIES of LICENSOR or other licensees, sub-licensees and franchisees of LICENSOR.

4.6

LICENSEE will permit LICENSOR or its authorised representative at all reasonable times to enter the LICENSEE’S premises where the PRODUCTS are made, stored, distributed or sold, for the purpose of inspection thereof. In order to enable LICENSOR to control the quality of the PRODUCTS, LICENSEE agrees to submit to LICENSOR after reasonable request random samples (up to 4 items per range of PRODUCTS) free of cost for inspection.

¹⁴ Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc. No. 10.128:14.

¹⁵Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc. No. 10.128:15.

-11-

4.7

If LICENSEE uses sub-manufacturers or sub-licensees, in accordance with the terms of this AGREEMENT for the manufacture of the PRODUCTS, LICENSEE shall remain liable for ensuring that the quality of the PRODUCTS remains in accordance with the QUALITY CRITERIA. LICENSEE shall permit or procure that the sub-manufacturer or sub-licensee shall permit the LICENSOR or its representative during normal business hours to enter any place of manufacture or storage occupied by or used by the sub-manufacturer or the sub-licensee for the purpose of inspection of the PRODUCTS and to ensure that the QUALITY CRITERIA are being adhered to. PROVISIONS for this purpose shall be incorporated into any sub-manufacturing contract or sub-license granted hereunder. LICENSEE undertakes to have executed by any of such sub-manufacturer and sub-licenses a declaration acknowledging LICENSOR’s intellectual property rights as provided by LICENSOR.

LICENSEE will use its best efforts to ensure that such suppliers which are branding any of the components of the PRODUCTS with any of the TRADEMARKS permit the LICENSOR or its representative either alone or together with LICENSEE or its representative within reasonable intervals and after reasonable notice during normal business hours to enter any place of manufacture or storage occupied or used by such suppliers for the purpose of inspection of the PRODUCTS and to ensure that the QUALITY CRITERIA are being adhered to.

4.8

The Parties agree that it is essential that the Products be marked “Made in France”. For that purpose, LICENSEE undertakes that any and all Products shall be manufactured in such a manner as to permit such marking in accordance with country of origin markings and regulations and any other relevant regulation in force during the term of this AGREEMENT in the Territory.

4.9

LICENSEE is informed that LICENSOR and the Richemont Group are engaged in respecting international treaties and guidlines in relation to, inter alia, protection of environment, labour conditions (no child labour) and testing of products (no tests on animals), and LICENSEE undertakes to carry out this AGREEMENT in full respect of aforesaid.

5. MARKETING AND LAUNCH PLANS, ADVERTISING, MARKETING AND SALES PROMOTION

-12-

5.1

LICENSEE shall, on a [---------------]¹⁶, and in each calendar year, communicate in writing to LICENSOR and follow such communication within [---------------]¹⁷, or within such other period as the parties may agree, with a presentation for discussion purposes at LICENSOR’S premises, or at such other location as may be agreed, the following:

(a)	its marketing plan for the following [---------------]¹⁸period to include the information set out in Annex F hereto;

(b)

[---------------]¹⁹per calendar year, than its indicative Strategic Plan for the following [[---------------]²⁰, such Strategic Plan to include a market overview, LICENSEE’S strategy and marketing objectives, a marketing calendar and summary of planned advertising and promotional expenditure, brand positioning and pricing; and

(c)	any new PRODUCT launch plans, if relevant, in accordance with Section 5.3 below.

5.2	At the time LICENSEE presents its marketing plan in accordance with Section 5.1 (a) above, LICENSOR shall present its PRODUCT marketing plan for the following [---------------]²¹,

5.3	The launch plan for each new line of PRODUCTS shall be presented at the relevant marketing proposal presentation referred to in Section 5.1 above, or at a separate presentation if agreed by the parties.

¹⁶ Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc. No. 10.128:16.

¹⁷ Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc. No. 10.128:17.

¹⁸ Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc. No. 10.128:18.

¹⁹ Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc. No. 10.128:19.

²⁰ Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc. No. 10.128:20.

²¹ Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc. No. 10.128:21.

-13-

5.4

LICENSEE shall be responsible for producing and circulating all advertising and promotional materials in the TERRITORY at its costs. LICENSEE agrees to take LICENSOR’S image into consideration in its advertising and promotion for the PRODUCTS and to ensure that the advertising and promotion for the PRODUCTS will be in accordance with LICENSOR’S image and reputation and will not harm or diminish LICENSOR’S image and reputation and the goodwill LICENSOR has built up with its other products. LICENSEE further agrees to consult with LICENSOR with regard to advertising and sales promotion and to take LICENSOR’S advice into due consideration in order to develop advertising which is consistent with the image and reputation of LICENSOR.

5.5	The parties agree that LICENSOR shall have approval rights with regard to the advertising and marketing for the PRODUCTS over

the “central” marketing materials

the “central” PR releases

the “central” advertising material

major public relation events

(“central” means the initial core materials that will be sent by LICENSEE to international markets for translation and adaptation to local markets. It is thereby understood, that there will be no “local” marketing, PR and advertising material other than the translated or to the local needs adapted “central” marketing, PR and advertising material).

If LICENSOR does not consent to any of LICENSEE’S proposals with regard to the advertising and marketing for the PRODUCTS, it shall give its reasons for such withholding and agrees to submit its ideas, input and advice with regard thereto to LICENSEE within [---------------] ²² after having received such proposal. LICENSEE agrees to take LICENSOR’S comments, ideas, input and advice into consideration and amend or revise its proposal and/or implement LICENSOR’S suggestions and submit the revised proposal to LICENSOR for approval-it being understood that LICENSOR and LICENSEE shall use their best endeavours to closely cooperate in order to have finally a satisfactory common project.

5.6	LICENSEE undertakes to spend jointly with its distributors in each calendar year a minimum percentage of its PROJECTED NET SALES on advertising and marketing of the PRODUCTS (hereinafter called “Advertising and Marketing Expenditure”) as follows:

- First Contractual Year (or part thereof) [---------------]²³

For and on behalf of	For and on behalf of
LICENSOR	LICENSEE


Paris 19 June 2006	Paris 19 June 2006
place and date	place and date



/s/ Stanislas de QUERCIZE	/s/ Philippe BENACIN
Name: Stanislas de QUERCIZE	Name: Philippe BENACIN
Title: President	Title: President







/s/ Jörg SCHAUFELBERGER
Name: Jörg SCHAUFELBERGER
Title: General Manager

For and on behalf of	For and on behalf of
LICENSOR	LICENSEE






____________________________	_________________________
Name: Stanislas de QUERCIZE	Name: Philippe BENACIN
Title: President	Title: President







______________________________
Name: Jörg SCHAUFELBERGER
Title: General Manager


For and on behalf of	For and on behalf of
LICENSOR	LICENSEE




____________________________	_________________________
Name: Stanislas de QUERCIZE	Name: Philippe BENACIN
Title: President	Title: President







______________________________
Name: Jörg SCHAUFELBERGER
Title: General Manager

For and on behalf of	For and on behalf of
LICENSOR	LICENSEE






____________________________	_________________________
Name: Stanislas de QUERCIZE	Name: Philippe BENACIN
Title: President	Title: President




______________________________
Name: Jörg SCHAUFELBERGER
Title: General Manager

For and on behalf of	For and on behalf of
LICENSOR	LICENSEE






____________________________	_________________________
Name: Stanislas de QUERCIZE	Name: Philippe BENACIN
Title: President	Title: President




______________________________
Name: Jörg SCHAUFELBERGER
Title: General Manager

Germany	[---------------]
USA	[---------------]
France	[---------------]
Japan	[---------------]
Italy	[---------------]
UK	[---------------]
Spain	[---------------]⁴⁰

Date: November 7, 2006	By:	/s/ Jean Madar
		Jean Madar
		Chief Executive Officer


Date: November 7, 2006	By:	/s/ Russell Greenberg
		Russell Greenberg
		Executive Vice President,
		Chief Financial Officer and
		Principal Accounting Officer